Literature DB >> 33346636

TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects.

Arshpreet Kaur1, Deepender Kaushik1, Sakshi Piplani2,3, Surinder K Mehta1, Nikolai Petrovsky2,3, Deepak B Salunke1,4.   

Abstract

Toll-like receptors (TLRs) are the pattern recognition receptors (PRRs) that recognize pathogen-associated molecular patterns (PAMPs) in microbial species. Among the various TLRs, TLR2 has a special place due to its ability to sense the widest repertoire of PAMPs owing to its heterodimerization with either TLR1 or TLR6, broadening its ligand diversity against pathogens. Various scaffolds are reported to activate TLR2, which include naturally occurring lipoproteins, synthetic lipopeptides, and small heterocyclic molecules. We described a detailed SAR in TLR2 agonistic scaffolds and also covered the design and chemistry for the conjugation of TLR2 agonists to antigens, carbohydrates, polymers, and fluorophores. The approaches involved in delivery of TLR2 agonists such as lipidation of antigen, conjugation to polymers, phosphonic acids, and other linkers to achieve surface adsorption, liposomal formulation, and encapsulating nanoparticles are elaborated. The crystal structure analysis and computational modeling are also included with the structural features that facilitate TLR2 activation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33346636     DOI: 10.1021/acs.jmedchem.0c01627

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Insight into potent TLR2 inhibitors for the treatment of disease caused by Mycoplasma pneumoniae based on machine learning approaches.

Authors:  Muhammad Ishfaq; Ziaur Rahman; Muhammad Aamir; Ihsan Ali; Yurong Guan; Zhihua Hu
Journal:  Mol Divers       Date:  2022-04-29       Impact factor: 2.943

2.  Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune Response.

Authors:  Ming-Hsiu Yang; Jamie L Russell; Yuto Mifune; Ying Wang; Hexin Shi; Eva Marie Y Moresco; Daniel J Siegwart; Bruce Beutler; Dale L Boger
Journal:  J Med Chem       Date:  2022-06-29       Impact factor: 8.039

3.  Synthesis, structure-activity relationship studies and evaluation of a TLR 3/8/9 agonist and its analogues.

Authors:  Anindya Sarkar; Anushka C Galasiti Kankanamalage; Qian Zhang; Heng Cheng; Prasanna Sivaprakasam; Joseph Naglich; Chunshan Xie; Sanjeev Gangwar; Dale L Boger
Journal:  Med Chem Res       Date:  2021-05-18       Impact factor: 2.351

4.  Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants.

Authors:  Arshpreet Kaur; Sakshi Piplani; Deepender Kaushik; Johnson Fung; Isaac G Sakala; Yoshikazu Honda-Okubo; Surinder K Mehta; Nikolai Petrovsky; Deepak B Salunke
Journal:  RSC Med Chem       Date:  2022-04-20

Review 5.  The Role of TLR2 in Infectious Diseases Caused by Mycobacteria: From Cell Biology to Therapeutic Target.

Authors:  Wanbin Hu; Herman P Spaink
Journal:  Biology (Basel)       Date:  2022-02-05

Review 6.  Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities.

Authors:  Diego A Díaz-Dinamarca; Michelle L Salazar; Byron N Castillo; Augusto Manubens; Abel E Vasquez; Fabián Salazar; María Inés Becker
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

Review 7.  Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles.

Authors:  Deepender Kaushik; Arshpreet Kaur; Nikolai Petrovsky; Deepak B Salunke
Journal:  RSC Med Chem       Date:  2021-05-14

Review 8.  Pattern recognition receptors in health and diseases.

Authors:  Danyang Li; Minghua Wu
Journal:  Signal Transduct Target Ther       Date:  2021-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.